混合质细胞瘤:一个多中心系列,揭示了多种体质突变和对向治疗的反应
Joshua S Friedman1, Benjamin H Durham2,3,4, Anne S Reiner5
1Departments of Neurology, Neurosurgery, and Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
British journal of haematology
|April 13, 2024
概括
混合囊细胞瘤 (MXH) 呈现出多种突变,对传统疗法反应不佳. 向治疗,包括BRAF和MEK抑制剂,显著改善了这些罕见疾病的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 囊性瘤是克隆性造血性疾病,通过瘤透和全身炎症引起疾病.
- 常见的亚型包括朗格汉斯细胞囊炎 (LCH),罗莎-多夫曼-德斯托姆斯病 (RDD) 和埃尔德海姆-切斯特病 (ECD).
- 混合囊性瘤 (MXH),涉及两个或两个以上共存的亚型,是不太了解.
研究的目的:
- 为了研究临床表型,瘤原因驱动突变和活检证明的MXH.患者的治疗反应.
- 为了在MXH中比较传统疗法与向疗法 (BRAF或MEK抑制剂) 的疗效.
主要方法:
- 国际合作分析了27名活检证明的MXH.患者.
- 组成疾病亚型的表征和瘤原因驱动突变的鉴定.
- 使用重复测量概括估计方程进行统计分析,以比较治疗反应.
主要成果:
- 研究了27名MXH患者,包括ECD/LCH (19),ECD/RDD (6),RDD/LCH (1) 和ECD/RDD/LCH (1).
- 在MXH中发现了新的突变,例如KRAS,MAP2K2,MAPK3,非V600-BRAF,RAF1和BICD2-BRAF融合.
- 与传统疗法相比,向疗法显著更有可能达到完全响应,部分响应或稳定疾病 (OR: 17.34),并且不太可能导致疾病进展 (OR: 0.08).
结论:
- 囊性瘤表现出显著的临床和分子多样性.
- MXH对传统疗法反应不佳,但对向治疗有很高的敏感性.
- 针对性疗法代表了混合囊细胞性瘤患者更有效的治疗模式.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


